These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Modulation of μ-opioid receptor activation by acidic pH is dependent on ligand structure and an ionizable amino acid residue. Meyer J; Del Vecchio G; Seitz V; Massaly N; Stein C Br J Pharmacol; 2019 Dec; 176(23):4510-4520. PubMed ID: 31355457 [TBL] [Abstract][Full Text] [Related]
8. Evolving acidic microenvironments during colitis provide selective analgesic targets for a pH-sensitive opioid. Degro CE; Jiménez-Vargas NN; Tsang Q; Yu Y; Guzman-Rodriguez M; Alizadeh E; Hurlbut D; Reed DE; Lomax AE; Stein C; Bunnett NW; Vanner SJ Pain; 2023 Nov; 164(11):2501-2515. PubMed ID: 37326658 [TBL] [Abstract][Full Text] [Related]
9. Structural Assessment of Agonist Efficacy in the μ-Opioid Receptor: Morphine and Fentanyl Elicit Different Activation Patterns. Ricarte A; Dalton JAR; Giraldo J J Chem Inf Model; 2021 Mar; 61(3):1251-1274. PubMed ID: 33448226 [TBL] [Abstract][Full Text] [Related]
10. Uncovering the analgesic effects of a pH-dependent mu-opioid receptor agonist using a model of nonevoked ongoing pain. Massaly N; Temp J; Machelska H; Stein C Pain; 2020 Dec; 161(12):2798-2804. PubMed ID: 32639370 [TBL] [Abstract][Full Text] [Related]
11. Agonist that activates the µ-opioid receptor in acidified microenvironments inhibits colitis pain without side effects. Jiménez-Vargas NN; Yu Y; Jensen DD; Bok DD; Wisdom M; Latorre R; Lopez C; Jaramillo-Polanco JO; Degro C; Guzman-Rodriguez M; Tsang Q; Snow Z; Schmidt BL; Reed DE; Lomax AE; Margolis KG; Stein C; Bunnett NW; Vanner SJ Gut; 2022 Apr; 71(4):695-704. PubMed ID: 33785555 [TBL] [Abstract][Full Text] [Related]
12. Affinity, potency, efficacy, selectivity, and molecular modeling of substituted fentanyls at opioid receptors. Eshleman AJ; Nagarajan S; Wolfrum KM; Reed JF; Nilsen A; Torralva R; Janowsky A Biochem Pharmacol; 2020 Dec; 182():114293. PubMed ID: 33091380 [TBL] [Abstract][Full Text] [Related]
13. Amelioration of injury-induced tissue acidosis by a nonsteroidal analgesic attenuates antinociceptive effects of the pH-dependent opioid agonist NFEPP. Celik MÖ; Negrete R; Di Rosso R; Machelska H; Stein C Sci Rep; 2022 Sep; 12(1):15172. PubMed ID: 36071140 [TBL] [Abstract][Full Text] [Related]
14. How mu-Opioid Receptor Recognizes Fentanyl. Vo QN; Mahinthichaichan P; Shen J; Ellis CR Res Sq; 2020 Sep; ():. PubMed ID: 32935088 [TBL] [Abstract][Full Text] [Related]
16. Fentanyl-Type Antagonist of the μ-Opioid Receptor: Important Role of Axial Chirality in the Active Conformation. Arita H; Tanaka R; Kikukawa S; Tomizawa T; Sakata H; Funada M; Tomiyama K; Hashimoto M; Tasaka T; Tabata H; Nakamura K; Makino K; Oshitari T; Natsugari H; Takahashi H J Med Chem; 2024 Jun; 67(12):10447-10463. PubMed ID: 38869493 [TBL] [Abstract][Full Text] [Related]
17. Chronic fentanyl treatments induce the up-regulation of mu opioid receptor mRNA in rat pheochromocytoma cells. Yoshikawa M; Nakayama H; Ueno S; Hirano M; Hatanaka H; Furuya H Brain Res; 2000 Mar; 859(2):217-23. PubMed ID: 10719067 [TBL] [Abstract][Full Text] [Related]
18. Distinct Profiles of Desensitization of µ-Opioid Receptors Caused by Remifentanil or Fentanyl: In Vitro Assay with Cells and Three-Dimensional Structural Analyses. Uezono E; Mizobuchi Y; Miyano K; Ohbuchi K; Murata H; Komatsu A; Manabe S; Nonaka M; Hirokawa T; Yamaguchi K; Iseki M; Uezono Y; Hayashida M; Kawagoe I Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37176075 [TBL] [Abstract][Full Text] [Related]
19. Novel multi-objective affinity approach allows to identify pH-specific μ-opioid receptor agonists. Secker C; Fackeldey K; Weber M; Ray S; Gorgulla C; Schütte C J Cheminform; 2023 Sep; 15(1):85. PubMed ID: 37726792 [TBL] [Abstract][Full Text] [Related]
20. Effectiveness comparisons of G-protein biased and unbiased mu opioid receptor ligands in warm water tail-withdrawal and drug discrimination in male and female rats. Schwienteck KL; Faunce KE; Rice KC; Obeng S; Zhang Y; Blough BE; Grim TW; Negus SS; Banks ML Neuropharmacology; 2019 May; 150():200-209. PubMed ID: 30660628 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]